SCHEMBL7367863

SCHEMBL7367863

CCCCCNC(=O)c1cc([N+](=O)[O-])ccc1NC1CCCC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 4/20 0.66
SLC6A2 P23975 1/20 0.66
SLC6A4 P31645 1/20 0.66
DRD3 P35462 1/20 0.66
MAPT P10636 4/20 0.60
KMT2A Q03164 1/20 0.57
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 1/20 0.54
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
CA12 O43570 3/20 0.51
CA1 P00915 3/20 0.51
CA2 P00918 3/20 0.51
CA3 P07451 3/20 0.51
CA6 P23280 3/20 0.51
CA5A P35218 3/20 0.51
CA7 P43166 3/20 0.51
CA9 Q16790 3/20 0.51
CA14 Q9ULX7 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939916 1.00 TBXA2R (0.66) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6945457 0.99 TBXA2R (0.67) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL7367027 0.97 TBXA2R (0.61) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6943602 0.90 MAPT (0.61) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6945212 0.89 MAPT (0.57) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL27534799 0.86 MAPT (0.56) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6938854 0.85 MAPT (0.65) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6937085 0.82 MAPT (0.67) MAPTKMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL7369875 0.81 MAPT (0.66) TBXA2RSLC6A2SLC6A4DRD3MAPT
SCHEMBL6939682 0.81 MAPT (0.63) TBXA2RSLC6A2SLC6A4DRD3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001030745-A1 ANTHRANILIC ACID DERIVATIVES AS INHIBITORS OF THE CGMP-PHOSPHODIESTERASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-03 WO disclosed